Biotransformation of Drugs/ The main objectives of drug biotransformation include

Biotransformation of Drugs

Biotransformation of medicines, also known as drug metabolism, refers to the body’s process of transforming medications or xenobiotics (foreign compounds) into more water-soluble and readily excretable forms. The liver’s enzymes are mostly responsible for this transition, but the kidneys, lungs, and intestines all contribute.

The main objectives of drug biotransformation include:


Detoxification is a biological process that involves the removal or conversion of toxic substances, often by enzymatic reactions, to make them less harmful and more easily excretable from the body. This process is crucial for maintaining homeostasis and protecting the body from the harmful effects of various endogenous (produced within the body) and exogenous (originating outside the body) toxins.

In the context of drug metabolism and xenobiotics, detoxification primarily occurs in the liver through a series of enzymatic reactions. The liver is a key organ responsible for metabolizing and detoxifying various substances. The process involves two main phases: Phase I and Phase II reactions.

Phase I Reactions:

  1. Oxidation: Enzymes, such as cytochrome P450 (CYP), introduce oxygen atoms into drugs or toxins, making them more reactive and often creating intermediate metabolites.

  2. Reduction: Involves the addition of electrons to the substrate, resulting in a reduction in toxicity.

  3. Hydrolysis: Enzymatic cleavage of chemical bonds by the addition of water.

Phase II Reactions (Conjugation):

  1. Glucuronidation: Conjugation with glucuronic acid, increasing water solubility for easier excretion.

  2. Sulfation: Conjugation with sulfate, further increasing water solubility.

  3. Methylation: Addition of a methyl group to the substrate, often rendering it less toxic.

  4. Acetylation: Conjugation with acetyl groups.

These conjugation reactions in Phase II make the molecules more polar and hydrophilic, facilitating their elimination through urine or bile.

Detoxification is not limited to the liver; other organs, such as the kidneys, lungs, and intestines, also contribute to the removal of toxins from the body. The kidneys filter and excrete water-soluble substances from the bloodstream into urine, while the lungs eliminate volatile compounds through exhalation.

The detoxification process is essential for maintaining health and preventing the accumulation of harmful substances in the body. However, variations in individual genetics, environmental exposures, and lifestyle factors can influence the efficiency of detoxification processes. Some individuals may be more susceptible to adverse effects from certain toxins or drugs due to differences in their detoxification pathways. Understanding these processes is crucial for drug development, personalized medicine, and managing exposure to environmental toxins.

2.Facilitation of Elimination:

Facilitation of elimination is a key objective of drug biotransformation, aiming to make drugs more water-soluble and readily excretable from the body. This process involves converting drugs or their metabolites into forms that can be easily eliminated through urine or bile. The two main phases of drug biotransformation, phase I and phase II reactions, contribute to the facilitation of elimination:

  1. Phase I Reactions:

    • Oxidation: This phase I reaction increases the water solubility of drugs by introducing or exposing functional groups like hydroxyl (-OH) groups. The addition of an oxygen atom or removal of hydrogen makes the drug more polar and, therefore, more water-soluble. Cytochrome P450 enzymes, among others, play a crucial role in oxidation reactions.

    • Reduction: Involves the addition of electrons to the drug molecule, often leading to increased water solubility. While reduction reactions generally make drugs more polar, they can also be preparatory steps for subsequent phase II conjugation reactions.

    • Hydrolysis: This reaction involves the cleavage of a drug molecule by adding a water molecule. The resulting metabolites are usually more polar and easily excreted. Enzymes like esterases catalyze hydrolysis reactions.

  2. Phase II Reactions (Conjugation):

    • Glucuronidation: Conjugation with glucuronic acid significantly increases the water solubility of drugs, making them suitable for excretion through the urine. UDP-glucuronosyltransferase (UGT) enzymes catalyze this reaction.

    • Sulfation: Conjugation with sulfate groups enhances water solubility and facilitates elimination. Sulfotransferase enzymes are responsible for sulfation reactions.

    • Methylation: The addition of a methyl group, typically to oxygen, nitrogen, or sulfur atoms, can increase water solubility. Methyltransferase enzymes mediate methylation reactions.

    • Acetylation: Conjugation with acetyl groups, often involving the addition of an acetyl coenzyme A (CoA) molecule, increases water solubility. N-acetyltransferase enzymes catalyze acetylation reactions.

The overall result of these biotransformation reactions is the production of metabolites that are more polar and hydrophilic than the parent drug. This increased polarity facilitates their excretion through the kidneys into the urine or through the liver into the bile, leading to elimination from the body. The balance between phase I and phase II reactions, as well as individual variability in drug-metabolizing enzymes, influences the efficiency of drug elimination.

3.Activation or Inactivation:

Activation or inactivation during drug biotransformation refers to the alteration of a drug’s pharmacological activity through metabolic processes. In some cases, the administered drug may be inactive or less active in its original form and requires biotransformation to become pharmacologically active. Conversely, active drugs may be transformed into inactive or less active metabolites. These processes are crucial for regulating the duration and intensity of a drug’s effects and ensuring proper physiological responses. Here’s a brief overview:


  1. Prodrugs: Some drugs are administered in an inactive form and rely on biotransformation to become active. Enzymes in the body can convert these prodrugs into their active forms, often through phase I reactions such as oxidation, reduction, or hydrolysis.

    Example: Codeine is a prodrug that is metabolized to morphine, its active form, by the liver enzyme CYP2D6.


  1. Detoxification: Biotransformation can render drugs less pharmacologically active or completely inactive, contributing to the elimination of potentially harmful substances from the body.

  2. Conjugation Reactions: Phase II reactions, such as glucuronidation, sulfation, methylation, and acetylation, often lead to the formation of less active or inactive metabolites. Conjugation reactions increase water solubility and facilitate excretion.

    Example: Morphine, an active opioid, undergoes glucuronidation to form morphine-3-glucuronide, which is less pharmacologically active and can be readily excreted.

Understanding whether a drug undergoes activation or inactivation during biotransformation is critical for determining its therapeutic effects, potential side effects, and interactions with other drugs. Additionally, variations in drug metabolism among individuals, influenced by genetic factors and environmental factors, can contribute to variability in drug responses and the need for personalized medicine approaches.

Scroll to Top